Changes in multiple myeloma epidemiology in the last thirty years: A single centre experience

European Journal of Cancer

Volumn 42, Issue 3, 2006, Pages 396-402

  Zappasodi, Patrizia ^a   Corso, Alessandro ^a   Klersy, Catherine ^a   Pica, Gianmatteo ^a   Mangiacavalli, Silvia ^a   Varettoni, Marzia ^a   Rusconi, Chiara ^a   Pascutto, Cristiana ^a   Lazzarino, Mario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Complications; Epidemiology; Multiple myeloma; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; BONE PAIN; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; OVERALL SURVIVAL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL ANALYSIS;

EID: 31144451768     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.09.031     Document Type: Article

References (33)

1. F. Ong, J. Hermans, and E.M. Noordijk Presenting signs and symptoms in multiple myeloma: high percentage of stage III among patiens without apparent myeloma-associated symptoms Ann Hematol 70 1995 149 152
2. A. Riccardi, P.G. Gobbi, and G. Ucci Changing clinical presentation of multiple myeloma Eur J Cancer 27 11 1991 1401 1405
3. J. Bladé, D.H. Vesole, and M. Gertz Transplantation for multiple myeloma: who, when, how often? Patient selection and goals Blood 102 2003 3469 3477
4. A. Kumar, T. Loughran, and M. Alsina Management of multiple myeloma: a systematic review and critical appraisal of published studies Lancet Oncol 4 2003 293 304
5. A. Alegre, A. Granda, and C.M. Chamorro Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma:clinical results of 280 cases from the Spanish Registry Haematologica 87 2002 609 614
6. J.R. Berenson, A. Lichtenstein, and L. Porter Long term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events J Clin Oncol 16 1998 593 602
7. J.R. Berenson, R.A. Kyle, and K. Anderson American society of clinical oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma J Clin Oncol 20 17 2002 3719 3736
8. B.M.G. Durie, and S.E. Salmon A clinical staging system for multiple myeloma Cancer 36 1975 842 854
9. M. Attal, J.L. Harosseau, and A.M. Stoppa A prospective, randomised trial of autologous transplantation and chemotherapy in multiple myeloma New Engl J Med 335 1996 91 97
10. B.G. Durie, R.A. Kyle, and A. Belch Myeloma management guidelines: a consensus report from the scientific Advisors of the International Myeloma Foundation Hematol J 4 2003 379 398
11. UK Myeloma Forum Guidelines Working Group Diagnosis and management of multiple myeloma Br J Haematol 115 2001 522 540
12. M. Hjorth, L. Hellquist, and E. Holmberg Initial versus deferred Melphalan-Prednisone therapy for asymtomatic multiple myeloma stage I - a randomized study Eur J Haematol 50 1993 95 102
13. M. Attal, J.L. Harousseau, and T. Facon Single versus double autologous stem-cell transplantation for multiple myeloma New Engl J Med 349 26 2003 2495 2502
14. K.J. Phekoo, A. Schey, and M.A. Richards A population study to define the incidence and the survival of multiple myeloma in a National Health Service Region in UK Br J Haematol 127 2004 299 304
15. V. De Lisi Leukemias and multiple myeloma Epidemiol Prev 28 2004 97 101
16. P.M. Carli, J.W.W. Coebergh, A. Verdecchia the Eurocare Working group Variation in survival of adult patients with haematological malignancies in Europe since 1978 Eur J Cancer 34 1998 2253 2263
17. M. Sant, T. Aareleid, and F. Berrino Eurocare-3: survival of cancer patients diagnosed 1990-94, results and commentary Ann Oncol 14 Suppl. 5 2003 v61 v118
18. H.M. Lokhorst, P. Sonneveld, and L.F. Verdonck Intensive treatment for multiple myeloma: where do we stand? Br J Haematol 106 1999 18 27
19. R.A. Kyle, M.A. Gertz, and T.E. Witzig Review of 1027 patients with newly diagnosed multiple myeloma Mayo Clin Proc 78 2003 15 17
20. R.T. Greenlee, T. Murray, and S. Bolden Cancer statistics 2000 CA: Cancer J Clin 50 2000 7 33
21. J. Bladè, P. Fernandez-Llama, and F. Bosch Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution Arch Intern Med 158 17 1998 1889 1893
22. B.M. Augustson, G. Begum, and N.J. Barth Early mortality following diagnosis of multiple myeloma; analysis of patients entered into the UK Medical Research Council Trials 1980-2002 Blood 104 11 2004 #3465
23. B. Barlogie, S. Jagannath, and K.R. Desikan Total therapy with tandem transplant for newly diagnosed multiple myeloma Blood 93 1999 55 65
24. J.A. Child, G.J. Morgan, and F.E. Davies High dose chemotherapy with hematopoietic stem-cell rescue in multiple myeloma patients New Engl J Med 348 19 2003 1875 1883
25. J.J. Lahuerta, J. Martinez-Lopez, and J. De La Serna Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients Br J Haematol 109 2000 438 446
26. B. Barlogie, J. Shaughnessy, and G. Tricot Treatment of multiple myeloma Blood 103 2004 20 32
27. S.K. Kumar, T.M. Therneau, and M.A. Gertz Clinical course of patients with relapsed multiple myeloma Mayo Clin Proc 79 7 2004 867 874
28. R. Zeiser, B. Deschler, and H. Bertz Extramedullary versus medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome Bone Marrow Transplant 34 12 2004 1057 1065
29. C. Sanfructuoso, M.D. Caballero, and L. Vasquez relapse of multiple myeloma in extramedullary sites after autologous bone marrow transplantation Eur J Haematol 56 1996 181 183
30. A. Alegre, A. Granda, and C. Martinez-Chamorro Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry Haematologica 87 6 2002 609 614
31. J.R. Berenson, L.S. Rosen, and A. Howell Zoledronic acid reduces skeletal related events in patients with osteolytic metastases Cancer 91 7 2001 1191 1200
32. A. Corso, L. Arcaini, and S. Mangiacavalli Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role for the identification of high risk patients Haematologica 86 2001 394 398
33. A. Corso, P. Zappasodi, and C. Pascutto Urinary proteins in multiple myeloma: correlation with clinical parameters and diagnostic implications Ann Haematol 82 2003 487 491